| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | EP1223935B1 Use of gemifloxacin compounds against bacteria |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | CN101103028A Heteroaryl substituted quinolin-4-ylamine analogues |
| 01/09/2008 | CN101103018A Compounds for the treatment of CNS and amyloid associated diseases |
| 01/09/2008 | CN101099868A Material compound for synthesizing norfloxacin macromolecular prodrug with active monomer and preparation method thereof |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/08/2008 | US7317102 Diarylmethyl and related compounds |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317024 Obesity, diabetes, inflammatory and immune diseases |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/03/2008 | WO2008001956A1 Therapeutic agent for liver fibrosis |
| 01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
| 01/03/2008 | WO2008001213A1 An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium) |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000839A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/03/2008 | WO2008000409A1 New cxcr2 inhibitors |
| 01/03/2008 | WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 01/03/2008 | US20080004445 Aromatic amine derivative and organic electroluminescence device using the same |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004273 Inhibitors of VEGF and HGF receptor signaling; treating cell proliferative diseases; N-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-oxo-1-phenylpyrrolidine-3-carboxamide |
| 01/03/2008 | CA2656150A1 New cxcr2 inhibitors |
| 01/03/2008 | CA2654801A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1263716B1 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
| 01/01/2008 | US7314939 Compositions and methods for inhibiting TGF-β |
| 12/27/2007 | WO2007149211A1 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 12/27/2007 | WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 12/27/2007 | WO2007148775A1 Chain amine compound |
| 12/27/2007 | WO2007148208A2 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 12/27/2007 | WO2007148191A2 An improved process for the preparation of aripiprazole |
| 12/27/2007 | WO2007147217A1 Method of treatment of glioma brain tumour |
| 12/27/2007 | WO2007089634A3 Inhibitors of fatty acid synthase (fas) |
| 12/27/2007 | WO2007066336A3 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 12/27/2007 | US20070299262 heating carbostyril compound with high boiling solvent in hydrochloric acid under reflux, then acylating; by-product inhibition; for treatment of gastrointestinal disorders |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299107 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/27/2007 | US20070299106 Novel mycobacterial inhibitors |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
| 12/27/2007 | DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections |
| 12/27/2007 | CA2656825A1 Method of treatment and agents useful for same |
| 12/27/2007 | CA2655654A1 New carbonylated (aza)cyclohexanes as dopamine d3 receptor ligands |
| 12/26/2007 | EP1870414A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency |
| 12/26/2007 | EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870396A1 Benzyloxypropylamine derivative |
| 12/26/2007 | EP1869040A1 Dna-pk inhibitors |
| 12/26/2007 | EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 12/26/2007 | EP1799214B1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | CN101094830A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation |
| 12/26/2007 | CN100357302C Phosphorescent compounds and devices comprising the same |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357274C Diaryl-enynes |
| 12/26/2007 | CN100357265C Compounds useful as intermediates of 4-aminoquinoline deravative |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis |
| 12/25/2007 | US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/25/2007 | US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 12/25/2007 | US7311982 Addition polymer |
| 12/21/2007 | WO2007146824A2 Quinoline compounds and methods of use |
| 12/21/2007 | WO2007146072A2 Process for synthesizing piperazine-piperidine compounds |
| 12/21/2007 | WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors |
| 12/21/2007 | WO2007125547A9 Novel process for statins and its pharmaceutically acceptable salts thereof |
| 12/21/2007 | WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof |
| 12/21/2007 | WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/21/2007 | CA2655128A1 Quinoline compounds and methods of use |
| 12/21/2007 | CA2650934A1 Processes for synthesizing piperazine-piperidine compounds |
| 12/20/2007 | US20070293679 Diastereoselective Addition of Lithiated N-Methylimidazole on Sulfinimines |
| 12/20/2007 | US20070293547 Compounds and Compositions as Lxr Modulators |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293536 Salts and polymorphs of a potent antidiabetic compound |
| 12/20/2007 | US20070293535 Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the Dame |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293492 Quinoline Tachykinin Receptor Antagonists |
| 12/20/2007 | US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 12/20/2007 | US20070292718 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 12/20/2007 | DE20321542U1 Reinstes rac-1-{4-[2-Hydroxy-3-(5-quinolyloxy) propyl]-piperazin-1-ylß-2,2-diphenylethan-1-one-fumarat Purest rac-1- {4- [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazine-1-ylß-2,2-diphenylethan-1-one fumarate |
| 12/19/2007 | EP1867684A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
| 12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |
| 12/19/2007 | EP1866298A2 Hydroxysteroid dehydrogenase inhibitors |
| 12/19/2007 | EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 12/19/2007 | EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/19/2007 | CN100355734C Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 12/18/2007 | US7309718 Leukotriene D4 and E4 antagonists; antiasthmatic, antiallergic and antiinflammatory agents; oral absorbability, sustained action; such as [3-[(E)-2-(6,7-difluoroquinolin-2-yl)ethenyl]-5H-dibenzo[a,d]cyclohepten-5-yl]oxyacetic acid |
| 12/13/2007 | WO2007141529A1 Fluoridation method |
| 12/13/2007 | WO2007140980A1 Pyrrolidine derivatives useful as bace inhibitors |
| 12/13/2007 | WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |